2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests. Issue 1 (1st January 2021)
- Record Type:
- Journal Article
- Title:
- 2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests. Issue 1 (1st January 2021)
- Main Title:
- 2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests
- Authors:
- Zhou, Ye
Chen, Leiyu
Jiang, Tianshu
Fan, Liangfeng
Lei, Hang
Wang, Yuqing
Heililahong, Hasiyati
Mi, Jianqing
Du, Danxin
Miao, Tianhong
Xia, Rong
Wang, Xuefeng
Xiang, Dong
Cai, Xiaohong
Tang, Xiaofeng - Abstract:
- ABSTRACT: Objectives: Treating red blood cells (RBCs) with dithiothreitol (DTT) is a wildly-recommended to overcome the interference of the daratumumab (DARA) with blood compatibility testing. Nevertheless, DTT can be hard to obtain in the clinical laboratory, while its use in routine practice may be time-consuming. In the following study, we explored the feasibility of using a commercial 2-mercaptoethanol (2-ME) working solution or the time-saving Polybrene method to mitigate DARA interference. Methods: Antibody screening and cross-matching were performed using 2-ME or DTT-based indirect antiglobulin tests (IATs) and Polybrene method (with human IgG anti-E same IATs titer as DARA as positive control) on 37 samples. Most clinically important blood group antigens on RBCs were detected after treatment with 2-ME or DTT. Results: Treating RBCs with 2-ME eliminates the DARA interference with the antibody screening or cross-matching; yet, K antigen is denatured during treatment. DARA does not interfere with antibody screening and cross-matching via Polybrene method, while 2+ agglutinations of anti-E antibody with the same titer (IATs method) as DARA could be observed in the positive controls via this method. Conclusion: 2-ME-based IATs or Polybrene method could replace DTT-based IATs to mitigate DARA interference.
- Is Part Of:
- Hematology. Volume 26:Issue 1(2021)
- Journal:
- Hematology
- Issue:
- Volume 26:Issue 1(2021)
- Issue Display:
- Volume 26, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 26
- Issue:
- 1
- Issue Sort Value:
- 2021-0026-0001-0000
- Page Start:
- 365
- Page End:
- 370
- Publication Date:
- 2021-01-01
- Subjects:
- Daratumumab -- anti-CD38 -- 2-mercaptoethanol -- polybrene -- blood transfusion -- dithiothreitol -- blood compatibility testing -- indirect antiglobulin test
Blood -- Diseases -- Periodicals
Hematology -- Periodicals
Blood -- Transfusion -- Periodicals
616.15005 - Journal URLs:
- http://www.ingentaconnect.com/content/maney/hem ↗
https://www.tandfonline.com/journals/yhem20 ↗
http://maneypublishing.com/ ↗ - DOI:
- 10.1080/16078454.2021.1918916 ↗
- Languages:
- English
- ISSNs:
- 1024-5332
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4291.565000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25394.xml